Global Meningococcal Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Meningococcal Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Meningococcal Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Meningococcal Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Meningococcal Vaccine Segment by Type

2.2.1 Meningtits A

2.2.2 Polysaccharide Meningtitis AC

2.2.3 Meningitis ACYW

2.3 Meningococcal Vaccine Sales by Type

2.3.1 Global Meningococcal Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Meningococcal Vaccine Sale Price by Type (2017-2022)

2.4 Meningococcal Vaccine Segment by Application

2.4.1 6 Months-15Year

2.4.2 over 3 Year

2.4.3 over 2 Year

2.4.4 over 3 Months

2.5 Meningococcal Vaccine Sales by Application

2.5.1 Global Meningococcal Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Meningococcal Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Meningococcal Vaccine Sale Price by Application (2017-2022)

3 Global Meningococcal Vaccine by Company

3.1 Global Meningococcal Vaccine Breakdown Data by Company

3.1.1 Global Meningococcal Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Meningococcal Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Meningococcal Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Meningococcal Vaccine Revenue by Company (2020-2022)

3.2.2 Global Meningococcal Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Meningococcal Vaccine Sale Price by Company

3.4 Key Manufacturers Meningococcal Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Meningococcal Vaccine Product Location Distribution

3.4.2 Players Meningococcal Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Meningococcal Vaccine by Geographic Region

4.1 World Historic Meningococcal Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Meningococcal Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Meningococcal Vaccine Annual Revenue by Geographic Region

4.2 World Historic Meningococcal Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Meningococcal Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Meningococcal Vaccine Annual Revenue by Country/Region

4.3 Americas Meningococcal Vaccine Sales Growth

4.4 APAC Meningococcal Vaccine Sales Growth

4.5 Europe Meningococcal Vaccine Sales Growth

4.6 Middle East & Africa Meningococcal Vaccine Sales Growth

5 Americas

5.1 Americas Meningococcal Vaccine Sales by Country

5.1.1 Americas Meningococcal Vaccine Sales by Country (2017-2022)

5.1.2 Americas Meningococcal Vaccine Revenue by Country (2017-2022)

5.2 Americas Meningococcal Vaccine Sales by Type

5.3 Americas Meningococcal Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Meningococcal Vaccine Sales by Region

6.1.1 APAC Meningococcal Vaccine Sales by Region (2017-2022)

6.1.2 APAC Meningococcal Vaccine Revenue by Region (2017-2022)

6.2 APAC Meningococcal Vaccine Sales by Type

6.3 APAC Meningococcal Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Meningococcal Vaccine by Country

7.1.1 Europe Meningococcal Vaccine Sales by Country (2017-2022)

7.1.2 Europe Meningococcal Vaccine Revenue by Country (2017-2022)

7.2 Europe Meningococcal Vaccine Sales by Type

7.3 Europe Meningococcal Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Meningococcal Vaccine by Country

8.1.1 Middle East & Africa Meningococcal Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Meningococcal Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Meningococcal Vaccine Sales by Type

8.3 Middle East & Africa Meningococcal Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Meningococcal Vaccine

10.3 Manufacturing Process Analysis of Meningococcal Vaccine

10.4 Industry Chain Structure of Meningococcal Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Meningococcal Vaccine Distributors

11.3 Meningococcal Vaccine Customer

12 World Forecast Review for Meningococcal Vaccine by Geographic Region

12.1 Global Meningococcal Vaccine Market Size Forecast by Region

12.1.1 Global Meningococcal Vaccine Forecast by Region (2023-2028)

12.1.2 Global Meningococcal Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Meningococcal Vaccine Forecast by Type

12.7 Global Meningococcal Vaccine Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Meningococcal Vaccine Product Offered

13.1.3 Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Meningococcal Vaccine Product Offered

13.2.3 GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Meningococcal Vaccine Product Offered

13.3.3 Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 CSL

13.4.1 CSL Company Information

13.4.2 CSL Meningococcal Vaccine Product Offered

13.4.3 CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 CSL Main Business Overview

13.4.5 CSL Latest Developments

13.5 Baxter

13.5.1 Baxter Company Information

13.5.2 Baxter Meningococcal Vaccine Product Offered

13.5.3 Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Baxter Main Business Overview

13.5.5 Baxter Latest Developments

13.6 JN International Medical Corporation

13.6.1 JN International Medical Corporation Company Information

13.6.2 JN International Medical Corporation Meningococcal Vaccine Product Offered

13.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 JN International Medical Corporation Main Business Overview

13.6.5 JN International Medical Corporation Latest Developments

13.7 Serum Institute of India

13.7.1 Serum Institute of India Company Information

13.7.2 Serum Institute of India Meningococcal Vaccine Product Offered

13.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Serum Institute of India Main Business Overview

13.7.5 Serum Institute of India Latest Developments

13.8 Bio-Med

13.8.1 Bio-Med Company Information

13.8.2 Bio-Med Meningococcal Vaccine Product Offered

13.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bio-Med Main Business Overview

13.8.5 Bio-Med Latest Developments

13.9 China National Biotec Group

13.9.1 China National Biotec Group Company Information

13.9.2 China National Biotec Group Meningococcal Vaccine Product Offered

13.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 China National Biotec Group Main Business Overview

13.9.5 China National Biotec Group Latest Developments

13.10 Hualan Bio

13.10.1 Hualan Bio Company Information

13.10.2 Hualan Bio Meningococcal Vaccine Product Offered

13.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Hualan Bio Main Business Overview

13.10.5 Hualan Bio Latest Developments

13.11 Walvax

13.11.1 Walvax Company Information

13.11.2 Walvax Meningococcal Vaccine Product Offered

13.11.3 Walvax Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Walvax Main Business Overview

13.11.5 Walvax Latest Developments

13.12 Zhifei

13.12.1 Zhifei Company Information

13.12.2 Zhifei Meningococcal Vaccine Product Offered

13.12.3 Zhifei Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Zhifei Main Business Overview

13.12.5 Zhifei Latest Developments

14 Research Findings and Conclusion

Table 1. Meningococcal Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Meningococcal Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Meningtits A

Table 4. Major Players of Polysaccharide Meningtitis AC

Table 5. Major Players of Meningitis ACYW

Table 6. Global Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)

Table 7. Global Meningococcal Vaccine Sales Market Share by Type (2017-2022)

Table 8. Global Meningococcal Vaccine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Meningococcal Vaccine Revenue Market Share by Type (2017-2022)

Table 10. Global Meningococcal Vaccine Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)

Table 12. Global Meningococcal Vaccine Sales Market Share by Application (2017-2022)

Table 13. Global Meningococcal Vaccine Revenue by Application (2017-2022)

Table 14. Global Meningococcal Vaccine Revenue Market Share by Application (2017-2022)

Table 15. Global Meningococcal Vaccine Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global Meningococcal Vaccine Sales by Company (2020-2022) & (10K Pcs)

Table 17. Global Meningococcal Vaccine Sales Market Share by Company (2020-2022)

Table 18. Global Meningococcal Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Meningococcal Vaccine Revenue Market Share by Company (2020-2022)

Table 20. Global Meningococcal Vaccine Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers Meningococcal Vaccine Producing Area Distribution and Sales Area

Table 22. Players Meningococcal Vaccine Products Offered

Table 23. Meningococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Meningococcal Vaccine Sales by Geographic Region (2017-2022) & (10K Pcs)

Table 27. Global Meningococcal Vaccine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Meningococcal Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Meningococcal Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Meningococcal Vaccine Sales by Country/Region (2017-2022) & (10K Pcs)

Table 31. Global Meningococcal Vaccine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Meningococcal Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Meningococcal Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Meningococcal Vaccine Sales by Country (2017-2022) & (10K Pcs)

Table 35. Americas Meningococcal Vaccine Sales Market Share by Country (2017-2022)

Table 36. Americas Meningococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Meningococcal Vaccine Revenue Market Share by Country (2017-2022)

Table 38. Americas Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)

Table 39. Americas Meningococcal Vaccine Sales Market Share by Type (2017-2022)

Table 40. Americas Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)

Table 41. Americas Meningococcal Vaccine Sales Market Share by Application (2017-2022)

Table 42. APAC Meningococcal Vaccine Sales by Region (2017-2022) & (10K Pcs)

Table 43. APAC Meningococcal Vaccine Sales Market Share by Region (2017-2022)

Table 44. APAC Meningococcal Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Meningococcal Vaccine Revenue Market Share by Region (2017-2022)

Table 46. APAC Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)

Table 47. APAC Meningococcal Vaccine Sales Market Share by Type (2017-2022)

Table 48. APAC Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)

Table 49. APAC Meningococcal Vaccine Sales Market Share by Application (2017-2022)

Table 50. Europe Meningococcal Vaccine Sales by Country (2017-2022) & (10K Pcs)

Table 51. Europe Meningococcal Vaccine Sales Market Share by Country (2017-2022)

Table 52. Europe Meningococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Meningococcal Vaccine Revenue Market Share by Country (2017-2022)

Table 54. Europe Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)

Table 55. Europe Meningococcal Vaccine Sales Market Share by Type (2017-2022)

Table 56. Europe Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)

Table 57. Europe Meningococcal Vaccine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Meningococcal Vaccine Sales by Country (2017-2022) & (10K Pcs)

Table 59. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Meningococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)

Table 63. Middle East & Africa Meningococcal Vaccine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)

Table 65. Middle East & Africa Meningococcal Vaccine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Meningococcal Vaccine

Table 67. Key Market Challenges & Risks of Meningococcal Vaccine

Table 68. Key Industry Trends of Meningococcal Vaccine

Table 69. Meningococcal Vaccine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Meningococcal Vaccine Distributors List

Table 72. Meningococcal Vaccine Customer List

Table 73. Global Meningococcal Vaccine Sales Forecast by Region (2023-2028) & (10K Pcs)

Table 74. Global Meningococcal Vaccine Sales Market Forecast by Region

Table 75. Global Meningococcal Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Meningococcal Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Meningococcal Vaccine Sales Forecast by Country (2023-2028) & (10K Pcs)

Table 78. Americas Meningococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Meningococcal Vaccine Sales Forecast by Region (2023-2028) & (10K Pcs)

Table 80. APAC Meningococcal Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Meningococcal Vaccine Sales Forecast by Country (2023-2028) & (10K Pcs)

Table 82. Europe Meningococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Meningococcal Vaccine Sales Forecast by Country (2023-2028) & (10K Pcs)

Table 84. Middle East & Africa Meningococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Meningococcal Vaccine Sales Forecast by Type (2023-2028) & (10K Pcs)

Table 86. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Meningococcal Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Meningococcal Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Meningococcal Vaccine Sales Forecast by Application (2023-2028) & (10K Pcs)

Table 90. Global Meningococcal Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Meningococcal Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Meningococcal Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 93. Novartis Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 94. Novartis Meningococcal Vaccine Product Offered

Table 95. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. Novartis Main Business

Table 97. Novartis Latest Developments

Table 98. GSK Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 99. GSK Meningococcal Vaccine Product Offered

Table 100. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. GSK Main Business

Table 102. GSK Latest Developments

Table 103. Merck Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 104. Merck Meningococcal Vaccine Product Offered

Table 105. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Merck Main Business

Table 107. Merck Latest Developments

Table 108. CSL Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 109. CSL Meningococcal Vaccine Product Offered

Table 110. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. CSL Main Business

Table 112. CSL Latest Developments

Table 113. Baxter Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 114. Baxter Meningococcal Vaccine Product Offered

Table 115. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. Baxter Main Business

Table 117. Baxter Latest Developments

Table 118. JN International Medical Corporation Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 119. JN International Medical Corporation Meningococcal Vaccine Product Offered

Table 120. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 121. JN International Medical Corporation Main Business

Table 122. JN International Medical Corporation Latest Developments

Table 123. Serum Institute of India Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 124. Serum Institute of India Meningococcal Vaccine Product Offered

Table 125. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 126. Serum Institute of India Main Business

Table 127. Serum Institute of India Latest Developments

Table 128. Bio-Med Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 129. Bio-Med Meningococcal Vaccine Product Offered

Table 130. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 131. Bio-Med Main Business

Table 132. Bio-Med Latest Developments

Table 133. China National Biotec Group Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 134. China National Biotec Group Meningococcal Vaccine Product Offered

Table 135. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 136. China National Biotec Group Main Business

Table 137. China National Biotec Group Latest Developments

Table 138. Hualan Bio Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 139. Hualan Bio Meningococcal Vaccine Product Offered

Table 140. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 141. Hualan Bio Main Business

Table 142. Hualan Bio Latest Developments

Table 143. Walvax Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 144. Walvax Meningococcal Vaccine Product Offered

Table 145. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 146. Walvax Main Business

Table 147. Walvax Latest Developments

Table 148. Zhifei Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 149. Zhifei Meningococcal Vaccine Product Offered

Table 150. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 151. Zhifei Main Business

Table 152. Zhifei Latest Developments

List of Figures

Figure 1. Picture of Meningococcal Vaccine

Figure 2. Meningococcal Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Meningococcal Vaccine Sales Growth Rate 2017-2028 (10K Pcs)

Figure 7. Global Meningococcal Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Meningococcal Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Meningtits A

Figure 10. Product Picture of Polysaccharide Meningtitis AC

Figure 11. Product Picture of Meningitis ACYW

Figure 12. Global Meningococcal Vaccine Sales Market Share by Type in 2021

Figure 13. Global Meningococcal Vaccine Revenue Market Share by Type (2017-2022)

Figure 14. Meningococcal Vaccine Consumed in 6 Months-15Year

Figure 15. Global Meningococcal Vaccine Market: 6 Months-15Year (2017-2022) & (10K Pcs)

Figure 16. Meningococcal Vaccine Consumed in over 3 Year

Figure 17. Global Meningococcal Vaccine Market: over 3 Year (2017-2022) & (10K Pcs)

Figure 18. Meningococcal Vaccine Consumed in over 2 Year

Figure 19. Global Meningococcal Vaccine Market: over 2 Year (2017-2022) & (10K Pcs)

Figure 20. Meningococcal Vaccine Consumed in over 3 Months

Figure 21. Global Meningococcal Vaccine Market: over 3 Months (2017-2022) & (10K Pcs)

Figure 22. Global Meningococcal Vaccine Sales Market Share by Application (2017-2022)

Figure 23. Global Meningococcal Vaccine Revenue Market Share by Application in 2021

Figure 24. Meningococcal Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Meningococcal Vaccine Revenue Market Share by Company in 2021

Figure 26. Global Meningococcal Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Meningococcal Vaccine Revenue Market Share by Geographic Region in 2021

Figure 28. Global Meningococcal Vaccine Sales Market Share by Region (2017-2022)

Figure 29. Global Meningococcal Vaccine Revenue Market Share by Country/Region in 2021

Figure 30. Americas Meningococcal Vaccine Sales 2017-2022 (10K Pcs)

Figure 31. Americas Meningococcal Vaccine Revenue 2017-2022 ($ Millions)

Figure 32. APAC Meningococcal Vaccine Sales 2017-2022 (10K Pcs)

Figure 33. APAC Meningococcal Vaccine Revenue 2017-2022 ($ Millions)

Figure 34. Europe Meningococcal Vaccine Sales 2017-2022 (10K Pcs)

Figure 35. Europe Meningococcal Vaccine Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Meningococcal Vaccine Sales 2017-2022 (10K Pcs)

Figure 37. Middle East & Africa Meningococcal Vaccine Revenue 2017-2022 ($ Millions)

Figure 38. Americas Meningococcal Vaccine Sales Market Share by Country in 2021

Figure 39. Americas Meningococcal Vaccine Revenue Market Share by Country in 2021

Figure 40. United States Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Meningococcal Vaccine Sales Market Share by Region in 2021

Figure 45. APAC Meningococcal Vaccine Revenue Market Share by Regions in 2021

Figure 46. China Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Meningococcal Vaccine Sales Market Share by Country in 2021

Figure 53. Europe Meningococcal Vaccine Revenue Market Share by Country in 2021

Figure 54. Germany Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country in 2021

Figure 61. Egypt Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Meningococcal Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Meningococcal Vaccine in 2021

Figure 67. Manufacturing Process Analysis of Meningococcal Vaccine

Figure 68. Industry Chain Structure of Meningococcal Vaccine

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles